The system to malignancy care reveals notable contrasts between the United States and Europe . In the United States , healthcare is often highly decentralized , with a increased reliance on private plans and a inclination towards aggressive interventionist strategies, frequently at a higher price

While both the United States and Europe strive to provide optimal cancer care, their methods differ noticeably. The US often emphasizes advanced treatments, sometimes leading to increased costs. In contrast, European systems tend to prioritize preventive care and accessibility, focusing on early